Terbutaline Sulfate Tablet
NDC Package 71205-939-55
Package Information
Terbutaline Sulfate tablets is terbutaline is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease-COPD, bronchitis, emphysema). This formulation utilizes a tablet delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 71205-939 and is authorized under FDA application ANDA211832.
Identification & Billing
- RxCUI: 857677 - terbutaline sulfate 2.5 MG Oral Tablet
- RxCUI: 857683 - terbutaline sulfate 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71205 - Proficient Rx Lp
- 71205-939 - Terbutaline Sulfate
- 71205-939-55 - 500 TABLET in 1 BOTTLE
- 71205-939 - Terbutaline Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71205-939). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71205-939-55 identifies a specific commercial package of 500 tablet in 1 bottle of Terbutaline Sulfate, a human prescription drug labeled by Proficient Rx Lp. This product is billed for "EA" each discreet unit and contains an estimated amount of 500 billable units per package. This tablet is formulated for oral use and contains terbutaline sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on July 13, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Terbutaline is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease-COPD, bronchitis, emphysema). Terbutaline belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily.
How is this Proficient Rx Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71205093955. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.